• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人Ki-1淋巴瘤细胞系AMS3中,一种类似于Ltk的新型80 kDa蛋白酪氨酸激酶的过度磷酸化。

Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3.

作者信息

Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T, Mori S

机构信息

Department of Pathology, University of Tokyo, Japan.

出版信息

Oncogene. 1994 Jun;9(6):1567-74.

PMID:8183550
Abstract

Ki-1 lymphoma is a subtype of human malignant lymphoma characterized by the expression of CD30 (Ki-1) and a peculiar morphology. It is occasionally accompanied by a unique reciprocal chromosomal translocation t(2;5)(p23;q35). A Ki-1 lymphoma cell line, AMS3, was established by maintaining biopsied tumor cells in SCID (severe combined immunodeficiency) mice. To investigate abnormalities of the signal transduction in Ki-1 lymphomas, AMS3 lysate was immunoprecipitated with anti-phosphotyrosine monoclonal antibody, 25.2G4, and the immunoprecipitates were subjected to kinase assay and immuno-blotting with 25.2G4. A unique phosphotyrosine-containing protein of MW 80,000, designated p80, was found only in AMS3 cells and not in other cell lines or mononuclear cells from healthy donors. Subsequent amino acid sequence analysis of its tryptic digests showed that p80 was a hitherto undescribed tyrosine phosphoprotein similar to Ltk (leukocyte tyrosine kinase). Furthermore, physical interaction of p80 with CD30 was suggested from immunoprecipitation experiments with AMS3 lysates.

摘要

Ki-1淋巴瘤是人类恶性淋巴瘤的一种亚型,其特征为CD30(Ki-1)的表达和独特的形态学表现。它偶尔会伴有一种独特的相互染色体易位t(2;5)(p23;q35)。通过将活检的肿瘤细胞接种于SCID(严重联合免疫缺陷)小鼠体内,建立了一株Ki-1淋巴瘤细胞系AMS3。为了研究Ki-1淋巴瘤中信号转导的异常情况,用抗磷酸酪氨酸单克隆抗体25.2G4对AMS3裂解物进行免疫沉淀,然后对免疫沉淀物进行激酶分析并用25.2G4进行免疫印迹。发现一种分子量为80,000的独特含磷酸酪氨酸蛋白,命名为p80,仅在AMS3细胞中存在,而在其他细胞系或健康供体的单核细胞中不存在。随后对其胰蛋白酶消化产物进行氨基酸序列分析表明,p80是一种迄今未描述的酪氨酸磷蛋白,类似于Ltk(白细胞酪氨酸激酶)。此外,通过对AMS3裂解物进行免疫沉淀实验提示p80与CD30存在物理相互作用。

相似文献

1
Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3.在人Ki-1淋巴瘤细胞系AMS3中,一种类似于Ltk的新型80 kDa蛋白酪氨酸激酶的过度磷酸化。
Oncogene. 1994 Jun;9(6):1567-74.
2
Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry.应用免疫组织化学诊断与t(2;5)(p23;q35)相关的Ki-1淋巴瘤。
Blood. 1994 Dec 1;84(11):3648-52.
3
The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.源自恶性淋巴瘤的细胞系中的(2;5)(p23;q35)易位:霍奇金样细胞系中不存在t(2;5)。
Leukemia. 1996 Jan;10(1):142-9.
4
Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood.
Ann Oncol. 1997;8 Suppl 1:37-42.
5
Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.核磷蛋白-间变性淋巴瘤激酶(NPM-ALK),一种新型的热休克蛋白90(Hsp90)底物酪氨酸激酶:热休克蛋白90拮抗剂17-烯丙基氨基-17-去甲氧基格尔德霉素对ALK(+) CD30(+)淋巴瘤细胞中NPM-ALK表达及酪氨酸磷酸化的下调作用
Cancer Res. 2002 Mar 1;62(5):1559-66.
6
CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.CD30配体信号转导涉及霍奇金淋巴瘤细胞系中酪氨酸激酶和丝裂原活化蛋白激酶的激活。
Cancer Res. 1995 Sep 15;55(18):4157-61.
7
Identification of the human ltk gene product in placenta and hematopoietic cell lines.
Biochem Biophys Res Commun. 1993 Jan 29;190(2):674-9. doi: 10.1006/bbrc.1993.1101.
8
Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.表达新型嵌合蛋白p80NPM/ALK的间变性大细胞淋巴瘤:一种独特的临床病理实体。
Leukemia. 1997 Apr;11 Suppl 3:538-40.
9
A murine xenograft model for human CD30+ anaplastic large cell lymphoma. Successful growth inhibition with an anti-CD30 antibody (HeFi-1).一种用于人类CD30+间变性大细胞淋巴瘤的小鼠异种移植模型。用抗CD30抗体(HeFi-1)成功抑制生长。
Am J Pathol. 1999 Oct;155(4):1353-9. doi: 10.1016/S0002-9440(10)65237-6.
10
In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenografts.未偶联的CD30单克隆抗体对人间变性大细胞淋巴瘤异种移植瘤的体内抗肿瘤作用。
Cancer Res. 1995 Nov 15;55(22):5335-41.

引用本文的文献

1
Therapeutic advances of targeting receptor tyrosine kinases in cancer.靶向治疗癌症受体酪氨酸激酶的治疗进展。
Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w.
2
Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment.从分子诊断到当前治疗的炎性肌纤维母细胞瘤。
Oncol Res. 2024 Jun 20;32(7):1141-1162. doi: 10.32604/or.2024.050350. eCollection 2024.
3
Establishment and characterization of TK-ALCL1: a novel NPM-ALK-positive anaplastic large-cell lymphoma cell line.
建立并鉴定 TK-ALCL1:一种新型 NPM-ALK 阳性间变大细胞淋巴瘤细胞系。
Hum Cell. 2024 Jul;37(4):1215-1225. doi: 10.1007/s13577-024-01077-8. Epub 2024 May 16.
4
A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements and Mutations: Implications for Gastric Carcinogenesis and Target Therapy.间变性淋巴瘤激酶(ALK)重排与突变的研究进展:对胃癌发生机制及靶向治疗的启示
Curr Protein Pept Sci. 2024;25(7):539-552. doi: 10.2174/0113892037291318240130103348.
5
Anaplastic Lymphoma Kinase (ALK) in Posterior Cranial Fossa Tumors: A Scoping Review of Diagnostic, Prognostic, and Therapeutic Perspectives.后颅窝肿瘤中的间变性淋巴瘤激酶(ALK):诊断、预后及治疗前景的范围综述
Cancers (Basel). 2024 Feb 2;16(3):650. doi: 10.3390/cancers16030650.
6
Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function.嵌合激酶 ALK 诱导 NAMPT 的表达,并选择性地依赖这种代谢酶来维持其致癌功能。
Leukemia. 2023 Dec;37(12):2436-2447. doi: 10.1038/s41375-023-02038-0. Epub 2023 Sep 29.
7
Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma.间变大细胞淋巴瘤中白介素-1 受体通路的分析与治疗靶点。
Blood. 2023 Oct 12;142(15):1297-1311. doi: 10.1182/blood.2022019166.
8
LTK and ALK promote neuronal polarity and cortical migration by inhibiting IGF1R activity.LTK 和 ALK 通过抑制 IGF1R 活性促进神经元极性和皮质迁移。
EMBO Rep. 2023 Jul 5;24(7):e56937. doi: 10.15252/embr.202356937. Epub 2023 Jun 9.
9
Molecular Anatomy of the EML4-ALK Fusion Protein for the Development of Novel Anticancer Drugs.EML4-ALK 融合蛋白的分子解剖学用于新型抗癌药物的开发。
Int J Mol Sci. 2023 Mar 18;24(6):5821. doi: 10.3390/ijms24065821.
10
Tyrosine kinases in nodal peripheral T-cell lymphomas.淋巴结外周T细胞淋巴瘤中的酪氨酸激酶
Front Oncol. 2023 Feb 8;13:1099943. doi: 10.3389/fonc.2023.1099943. eCollection 2023.